A novel ciprofloxacin-resistant subclade of H58 Salmonella Typhi is associated with fluoroquinolone treatment failure
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel ciprofloxacin-resistant subclade of H58 Salmonella Typhi is associated with fluoroquinolone treatment failure
Authors
Keywords
-
Journal
eLife
Volume 5, Issue -, Pages -
Publisher
eLife Sciences Organisation, Ltd.
Online
2016-03-11
DOI
10.7554/elife.14003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial
- (2016) Amit Arjyal et al. LANCET INFECTIOUS DISEASES
- Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events
- (2015) Vanessa K Wong et al. NATURE GENETICS
- Antimicrobial resistance and management of invasive Salmonella disease
- (2015) Samuel Kariuki et al. VACCINE
- Emergence of Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi in Italy
- (2015) Aurora García-Fernández et al. PLoS One
- Genomic Dissection of Travel-Associated Extended-Spectrum-Beta-Lactamase-Producing Salmonella enterica Serovar Typhi Isolates Originating from the Philippines: a One-Off Occurrence or a Threat to Effective Treatment of Typhoid Fever?
- (2014) Rene S. Hendriksen et al. JOURNAL OF CLINICAL MICROBIOLOGY
- First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan
- (2013) Chia-Jie Lee et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Gatifloxacin Versus Ofloxacin for the Treatment of Uncomplicated Enteric Fever in Nepal: An Open-Label, Randomized, Controlled Trial
- (2013) Samir Koirala et al. PLoS Neglected Tropical Diseases
- Differential Epidemiology of Salmonella Typhi and Paratyphi A in Kathmandu, Nepal: A Matched Case Control Investigation in a Highly Endemic Enteric Fever Setting
- (2013) Abhilasha Karkey et al. PLoS Neglected Tropical Diseases
- Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure
- (2013) Stephen Baker et al. eLife
- Highly Resistant Salmonella enterica Serovar Typhi with a NovelgyrAMutation Raises Questions about the Long-Term Efficacy of Older Fluoroquinolones for Treating Typhoid Fever
- (2012) Kanika Deshpande Koirala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Enteric fever in Cambodian children is dominated by multidrug-resistant H58 Salmonella enterica serovar Typhi with intermediate susceptibility to ciprofloxacin
- (2012) Kate Emary et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial
- (2011) Amit Arjyal et al. LANCET INFECTIOUS DISEASES
- The Influence of Reduced Susceptibility to Fluoroquinolones in Salmonella enterica Serovar Typhi on the Clinical Response to Ofloxacin Therapy
- (2011) Christopher M. Parry et al. PLoS Neglected Tropical Diseases
- Suitable Disk Antimicrobial Susceptibility Breakpoints Defining Salmonella enterica Serovar Typhi Isolates with Reduced Susceptibility to Fluoroquinolones
- (2010) C. M. Parry et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Typhoid in Kenya Is Associated with a Dominant Multidrug-Resistant Salmonella enterica Serovar Typhi Haplotype That Is Also Widespread in Southeast Asia
- (2010) S. Kariuki et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The Sequence Alignment/Map format and SAMtools
- (2009) H. Li et al. BIOINFORMATICS
- Global Trends in Typhoid and Paratyphoid Fever
- (2009) John A. Crump et al. CLINICAL INFECTIOUS DISEASES
- High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi
- (2008) Kathryn E Holt et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation